A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Clinical trial NCT02363946 · TERMINATED
Trial details
- NCT number
- NCT02363946
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.